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Abstract
The Hypoxia-inducible transcription Factor (HIF) represents an important adaptive mechanism under hypoxia, whereas
sustained activation may also have deleterious effects. HIF activity is determined by the oxygen regulated a-subunits HIF-1a
or HIF-2a. Both are regulated by oxygen dependent degradation, which is controlled by the tumor suppressor ‘‘von Hippel-
Lindau’’ (VHL), the gatekeeper of renal tubular growth control. HIF appears to play a particular role for the kidney, where
renal EPO production, organ preservation from ischemia-reperfusion injury and renal tumorigenesis are prominent
examples. Whereas HIF-1a is inducible in physiological renal mouse, rat and human tubular epithelia, HIF-2a is never
detected in these cells, in any species. In contrast, distinct early lesions of biallelic VHL inactivation in kidneys of the
hereditary VHL syndrome show strong HIF-2a expression. Furthermore, knockout of VHL in the mouse tubular apparatus
enables HIF-2a expression. Continuous transgenic expression of HIF-2a by the Ksp-Cadherin promotor leads to renal fibrosis
and insufficiency, next to multiple renal cysts. In conclusion, VHL appears to specifically repress HIF-2a in renal epithelia.
Unphysiological expression of HIF-2a in tubular epithelia has deleterious effects. Our data are compatible with
dedifferentiation of renal epithelial cells by sustained HIF-2a expression. However, HIF-2a overexpression alone is
insufficient to induce tumors. Thus, our data bear implications for renal tumorigenesis, epithelial differentiation and renal
repair mechanisms.
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Introduction
Mammalian cells require oxygen for energy homeostasis and
thus for maintenance of cellular function and integrity. On the
molecular level, adaption to reduced oxygen concentrations
(hypoxia) depends on the activation of the Hypoxia-inducible
Factor (HIF), which enables critical processes such as glycolysis,
angiogenesis and erythropoiesis [1]. HIF is a transcriptional
heterodimer, consisting of a constitutive ß-subunit and an oxygen
sensitive a-subunit, HIF-1a or HIF-2a. Both a-subunits are
regulated similarly [2], mainly by oxygen dependent hydroxylation
leading to ubiquitination and proteasomal destruction [3].
However, knockout experiments [4,5], tissue expression patterns
[6,7] and target gene specificity [8,9] indicate isoform specific roles
at least to some extent. Of note, in hypoxic rat kidneys HIF-1a
and HIF-2a display a strikingly separate expression pattern. The
former shows expression in tubular epithelia, whereas the latter
shows expression in interstitial and glomerular cells [6].
For a number of reasons, the kidney has played a seminal role in
understanding oxygen sensitive gene regulation. Despite a high
oxygen transport rate to the kidney, oxygen tensions are very
heterogeneous and in part lower as 10 mmHg [10]. Teleologically
this may explain why the prototype of oxygen regulated genes,
erythropoietin (EPO), is mainly induced in the kidney. Acute renal
failure by ischemia-reperfusion injury is greatly attenuated if
pharmacological preconditioning with HIF stabilizers is performed
[11,12]. Finally, the recognition component of the oxygen
responsive ubiquitin ligase complex, the von Hippel Lindau
(VHL) tumor suppressor [13], is a gatekeeper for growth control of
tubular epithelial cells in the kidney [14]. In humans, biallelic
inactivation of VHL leads to the development of renal cell
carcinoma (RCC) of the clear cell type, which occurs in the
hereditary VHL syndrome as well as in sporadic RCC. In mouse
tissue specific VHL knockout was not found to induce tumors, but
generated cysts either alone [15] or in conjunction with a PTEN
knockout [16].
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Human clear cell RCCs typically show global oxygen
independent activation of HIF-1a and HIF-2a [17,18]. Stabiliza-
tion of HIFa subunits in early lesions of human RCC may be a
decisive step in renal tumorigenesis [19]. Experimental studies
have shown that HIF-2a, and not HIF-1a, appears to be the
decisive subunit mediating tumorigenic features [20–23]. Mech-
anistically this may be due to a cellular proliferative effect of HIF-
2a, whereas HIF-1a may have opposite effects [22,24]. Never-
theless, overexpression of HIF-1a in murine proximal tubuli has
recently been shown to lead to RCC [25]. Constant activation of
HIF by genetic inactivation of VHL in tubular epithelia has
further shown to induce renal fibrosis [26], which may indicate a
common pathway of epithelial dedifferentiation.
In summary, HIF effects play an important role in the kidney,
which can be beneficial or deleterious, depending on the setting
and the timing. The specific roles of the different HIFa isoforms in
this context are not well defined. Furthermore, there is no
knowledge of the differential expression patterns of HIF-1a and
HIF-2a in the human kidney. Experimental data originates mostly
from VHL knockout studies in the mouse, where HIFa
stabilization is an inevitable consequence. However, other HIF
independent effects with oncogenic potential are known to be
released when VHL is inactivated [14]. We therefore aimed to
clearly define the physiological expression patterns of HIFa
subunits in normal kidney epithelial cells, as well as in response
to experimental VHL knockout and human VHL disease.
Furthermore, we aimed to study the tumorigenic potential of
tubular HIF-2a overexpression in a novel mouse model.
Results
Distinct expression patterns of HIF-1a and HIF-2a in
hypoxic mouse and human kidneys
Identically to the predescribed situation in the rat, we see
distinct expression patterns for the two HIFa subunits in mouse
(Figure 1) and man (Figure 2). Hypoxic human kidneys were
investigated from victims of carbon monoxide intoxication, where
the tissues are severely hypoxic due to the reduced oxygen
transport capacity of the haemoglobin and in kidney tissue
adjacent to RCCs, where hypoxic microenvironment is often
caused by expansive tumor growth. In all cases investigated,
hypoxia leads to HIF-1a accumulation exclusively in tubular
epithelial cells, whereas HIF-2a is stabilized in interstitial cells and
in glomeruli. Hypoxia does not enable HIF-2a expression in renal
tubular cells, in any species.
Inducible VHL knockout in mouse renal tubular cells
enables HIF-2a expression
We next studied HIF expression in an inducible murine VHL
knockout (VHL2/2) model, which was implied by the Pax8
promoter and confers an inducible Cre-driven knockout in the
complete tubular system of the kidney [27,28]. In these animals
VHL expression is lost after doxycycline treatment. Control
animals without doxycycline showed no expression of either HIFa
subunit (data not shown). In contrast to the physiological HIF
expression, the knockout mice showed tubular expression of HIF-
2a (and HIF-1a) in the tubules upon a 3-day treatment with
Figure 1. HIF-1a and HIF-2a expression in mouse kidney. The physiological expression pattern of HIF-1a and HIF-2a was analyzed by
immunohistochemistry on kidney sections of normoxic and hypoxic (6 h, 7% O2) mice. HIF-1a expression was detected in the nuclei of renal tubular
epithelial cells after hypoxic stimulation, whereas HIF-2a accumulated in interstitial and glomerular cells.
doi:10.1371/journal.pone.0031034.g001
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doxycyclin (Figure 3). Thus, it appears that VHL represses renal
tubular HIF-2a specifically.
Biallelic inactivation of VHL releases HIF-2a expression in
distinct early lesions of the distal tubule in kidneys of the
human VHL disease
Previously, we reported multiple premalignant lesions in tubules
of patients with VHL germline mutations, which were identified
on the basis of carbonic anhydrase 9 (CAIX) expression [19]. We
detected that these express HIF-1a, and had inactivation of the
wild type VHL allele. Subsequently we demonstrated, that these
foci in the distal tubule also displayed decreased expression of E-
cadherin [29]. In the light of the mouse data, we re-examined the
kidneys of VHL patients and observed additional foci of reduced
E-cadherin labelling, which did not express CAIX and little or no
HIF-1a, but did express HIF-2a (Figure 4 A). Thus there are (at
least) two distinct classes of foci of VHL inactivation, which we
now designate Type I (high CAIX, high HIF-1a) and Type II (no
CAIX and high HIF-2a) foci (see table 1). We also stained for
other markers, which are not expressed in normal renal tubules
but do show expression in clear cell RCCs; the glucose
transporter-1 (Glut1) and the intermediate filament vimentin. In
line with the hypothesis that these lesions contain precancerous
cells, the type II lesions stain clearly positive for vimentin and
Figure 2. Expression of HIF-1a and HIF-2a in the human kidney. HIF-1a and HIF-2a expression was analyzed by immunohistochemistry in
human kidneys. After carbon monoxide (CO) intoxication HIF-1a accumulation was detected in tubular epithelial cells (A) and HIF-2a was detected in
interstitial cells and in the glomeruli, indicated by arrows (B). In kidneys of RCC patients HIF-1a and HIF-2a were detected in the tumor tissue as well
as in the adjacent kidney (C and D). In the latter HIF-1a was found in tubular epithelial cells (E) and HIF-2a restricted to interstitial cells (F).
doi:10.1371/journal.pone.0031034.g002
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Glut1. Finally, in contrast to type I lesions the type II lesions show
intense labelling for cyclin D1 (Figure 4 B), which has already been
implicated to be a candidate of HIF-2 mediated tumorigenesis
[22].
Transgenic HIF-2a overexpression in renal tubular cells
leads to renal fibrosis
We generated a transgenic mouse model with constitutively
stable and active HIF-2a derived from a cDNA (tmHIF-2a.HA)
under the control of the kidney specific Ksp-promoter which
enables mainly distal tubular expression (Fig. 5, S1 and S2).
Kidneys of tmHIF-2a.HA(+) mice at the ages of 3, 6 and 9 months
displayed no pathology regarding gross morphology and histology
(data not shown). We therefore decided to let the mice grow to an
age of 14–16 month. Figure 6 A shows representative photographs
of the kidneys from tmHIF-2a.HA(2) and tmHIF-2a.HA(+) mice
at this age. Obvious morphological differences can already be seen
on the surface of kidneys from these two strains. The kidneys of
tmHIF-2a.HA(2) control mice displayed a uniform smooth surface
(Figure 6 A, left), whereas the kidneys of tmHIF-2a.HA(+) mice
had an irregular and rough appearance (Figure 6 A, right). tmHIF-
2a.HA(+) mice had a significantly reduced kidney weight as judged
by kidney to body weight ratio (Figure S3 A). Histological analysis
of the kidneys from aged animals was performed. The retracted
organ surface implicated fibrotic events within the kidney.
Therefore, total collagen as a fibrosis marker was stained by
SiriusRed (Figure S3 B) and the level of tissue fibrosis was scored
by a blinded analysis (Figure 6 C). The tmHIF-2a.HA(+) kidneys
showed a strong increase of fibrotic tissue in comparison to tmHIF-
2a.HA(2) kidneys. Furthermore, staining for collagen I revealed
increased expression in tmHIF-2a.HA(+) mice (Figure 6 B, upper
panel), whereas tmHIF-2a.HA(2) kidneys showed collagen I
expression only to a minor extent (data not shown). Consecutive
sections stained for collagen I and tmHIF-2a.HA revealed a clear
spatial relationship between the transgenic HIF-2a expression and
the areas of fibrosis (Figure 6 B). Real-time PCR for the fibrosis
associated gene TGFb1 in total kidney RNA extracts showed
strong upregulation in tmHIF-2a.HA(+) compared to tmHIF-
2a.HA(2) kidneys (Figure 6 D). We additionally determined
plasma parameters for renal function. Besides a slight increase in
urea (data not shown), tmHIF-2a.HA(+) mice had significantly
increased creatinine levels (Figure 6 E), confirming impaired renal
function.
Real-time PCR analysis for HIF target genes from whole kidney
lysates of the aged transgenic mice showed a strong induction of
PHD3 and a moderate induction of TGFa and Glut1 in the
tmHIF-2a.HA(+) mice (Figure S3 C). Since VEGF expression was
induced as well and angiogenesis is believed to be a classical
function of HIF, we histologically analyzed kidney capillarization
in our transgenic mice. Kidney sections were stained for the
endothelial marker MECA-32 by immunohistochemistry and the
vascularization level was determined by counting positively stained
capillaries in a blinded fashion. Compared to the tmHIF-2a.HA(2)
control group, tmHIF-2a.HA expression led to a significant
increase in kidney vascularization (Figure S3 D). However, EPO
expression was not induced in tmHIF-2a.HA(+) mice and
hematocrit not increased (data not shown).
Transgenic HIF-2a overexpression in tubular cells leads to
renal cyst formation
In addition to the fibrotic phenotype, the histological analysis of
the tmHIF-2a.HA(+) transgenic mice revealed frequent formation
Figure 3. VHL knockout in mice releases tubular HIF-2a expression. HIF-1a and HIF-2a expression was analyzed by immunohistochemistry in
the kidney cortex (upper panels) and medulla (lower panels) of inducible triple transgenic Pax8-VHL2/2 mice after 3 days of doxycyclin treatment
(0.2 mg/ml in drinking water). HIF-1a as well as HIF-2a expression appears in renal tubular epithelial cells.
doi:10.1371/journal.pone.0031034.g003
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of cysts in the renal cortex, which was not observed in the control
strain (Figure 7). Higher magnification of the cysts showed the
presence of a single epithelial cell layer lining the cystic lumen in
all cases (Figure 7 C and D). Interestingly, there appeared to be
two different types of cysts in the tmHIF-2a.HA(+) kidneys.
Approximately half of the cysts derive from the proximal tubule
immediately surrounding the glomeruli and often displaying the
glomerulum inside the structure (glomerular cysts; Figure 7 A
(marked by arrows) and D). The second group of cysts (termed
tubular cysts) appear to derive directly from the distal tubules,
since immunohistological staining against the HA-tag detected
tmHIF-2a.HA expression in the nuclei of several cells of the cystic
epithelium (Figure 7 C). In contrast, the epithelial cells lining the
glomerular cysts show no nuclear labelling (Figure 7 D), whereas
tubular segments in the vicinity stain positive for the transgene.
Transgene expressing tubular segments appear to have normal
numbers of cilia, where HIF-mediated reduction of cilia could
have been a mechanism leading to cysts (Figure S4).
Discussion
The transcription factor HIF is widely recognized as a critical
mediator of many (patho)physiological processes and is currently
under evaluation as a putative therapeutic target either by
Figure 4. De-repression of HIF-2a in type II lesions of VHL disease kidneys. Early lesions of human VHL disease kidneys were stained for
markers of epithelial dedifferentiation and HIF activation. A. Type II lesions are characterized by reduced E-cadherin expression, no expression of CAIX
and little or no staining of HIF-1a. In contrast, strong staining for vimentin, Glut1 and HIF-2a can be seen. B. Type II lesions show pronounced
upregulation of the HIF-2a target cyclin D1.
doi:10.1371/journal.pone.0031034.g004
Table 1. Immunohistochemical labeling of type I and II foci in
human VHL kidneys.
Protein Type I foci Type II foci
CAIX + 2
E-cadherin 2 2
Glut1 + +
HIF-1a + 2 (+)
HIF-2a 2 (+) +
Vimentin + +
Qualitative results for different stained proteins are shown as either not
detectable (2) in early lesions or clearly detectable (+).
doi:10.1371/journal.pone.0031034.t001
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inhibition for tumor therapy or activation for organ protection.
However, the spectrum of short and long term effects of HIF
manipulation are difficult to foresee. Our study shows that
constitutive aberrant overexpression of HIF-2a is sufficient to
induce a complex type of kidney disease associated with tubular
cyst formation, interstitial fibrosis and declining renal function, yet
no development of RCC. These data bare implications for
improved understanding of cellular control of HIF expression and
its effects, as well as development and progression of kidney
disease.
Renal tubular HIF expression
We show that the distinct expression pattern for HIF-1a and
HIF-2a in the kidney is stable across species and whatever stimulus
is used (oxygen deprivation, application of prolyl hydroxylase
inhibitors [11,12] or neighbourhood to RCC). The molecular
mechanism of differential control of HIFa expression remains
elusive, where transcriptional, translational or posttranslational
mechanisms could contribute. Importantly, when VHL is
inactivated in renal tubular cells in mice or human VHL disease,
we do see HIF-2a expression in these cells. The same has been
described previously in another conditional VHL deletion model,
although the authors did not compare the HIF-2a expression to
microenvironmental stimulation [16]. This could mean, that VHL
in some way specifically suppresses the expression of HIF-2a in
tubular epithelial cells, which may have interesting implications for
renal tumorigenesis. This is further supported by our findings in
the early renal lesions of the human VHL disease. Type II foci
show expression of HIF-2a, which is followed by upregulation of
the proliferative target gene cyclin D1, which has been implicated
in renal tumorigenesis before [22]. Accordingly, early studies have
described a VHL dependent expression in RCC cells, which was
more inclined to influence HIF-2a, rather than HIF-1a [18,30].
Renal cell carcinoma
The development of VHL associated clear cell RCC appears to
be closely linked to HIF activation. It has been demonstrated that
accumulation of HIF-1a and HIF-2a is a feature of very early
tumorigenesis in kidneys derived from patients with the hereditary
VHL syndrome, which can be verified already at a single cell level
[19]. HIF-2a (and not HIF-1a) appears to be the decisive factor for
growth initiation of experimental tumors. Functionally this may
occur via pro-proliferative effects of HIF-2a, which may be
mediated by cMyc signalling [24] and which can be verified in a
subgroup of RCCs expressing HIF-2a only [31]. Thus, accumu-
lating data has been published over the last decade implicating
that HIF-2a activation is a seminal oncogenic hit in renal
tumorigenesis as well as numerous other tumor entities, playing a
further important role in tumor growth and behaviour [32]. We
show that biallelic VHL inactivation releases HIF-2a expression in
renal tubular cells. Therefore, this process could be an important
event in the development of RCC. Nevertheless, our data also
show that HIF-2a activation on its own is not sufficient to induce
renal tumors in the mouse, which is similar to two further murine
models who have deleted VHL in tubular cells [15,16]. The lack of
tumors in our and most other mouse models may be a result of the
absence of crucial additional oncogenic events. Accordingly, it has
been estimated that numerous mutational events are necessary to
establish a malignant tumor, which is capable of enforcing itself in
a hostile microenvironment [26]. However, HIF-1a overexpres-
sion in the proximal tubule seems sufficient to induce tumors in
mice [25]. Thus, the particular segment of the renal tubule may
also be of importance.
Renal cystic disease
Regulation of renal tubular cell polarity and proliferation is
strongly linked with the functional integrity of the primary cilium
and ciliary defects often cause the development of renal cysts [33].
Intriguingly, recent data have shown that VHL and/or HIF play
an important role in ciliary biology (for review see [34]).
Consequently, two studies have demonstrated the development
of renal cysts when VHL is inactivated in tubular cells with or
without consecutive deletion of PTEN, respectively [15,16]. It is
not clear from these studies, which HIFa isoform mainly
contributed to cyst development, although one study suspected
HIF-2a to be the driving force, since simultaneous HIF-2a
knockouts did not show cysts [15].
In human autosomal dominant polycystic kidney disease
(ADPKD) HIF is also activated, but follows the ‘‘physiological’’
expression pattern of tubular HIF-1a and peritubular HIF-2a
[35]. Of note, primary cystic diseases such as ADPKD rarely show
the development of RCC, whereas acquired renal cysts and cysts
in the hereditary VHL syndrome are regarded as precancerous
lesions [34]. Whether the reason for these differences lie within
HIF-2a expression of cystic epithelia remains speculative to date
and is under investigation.
Chronic kidney disease (CKD)
A large body of evidence exists showing that HIF activation can
be beneficial in acute kidney injury models [11,36,37]. In CKD
the situation is less clear although chronic hypoxia is considered to
play a role in the development of progressive tubulointerstitial
fibrosis and the development of CKD [38,39]. Pharmacological
HIF activation has been shown to be protective in chronic models
of the remnant kidney by increase of peritubular angiogenesis [40],
in the Thy1 nephritis [41] or models of diabetic nephropathy [42].
Nevertheless, HIF-1 appears to be an important mediator of CKD
by chronic hypoxia, which is caused by EMT and subsequent
fibrosis [26]. Furthermore, stable expression of HIF-1a in tubular
epithelial cells seems to be sufficient to promote interstitial fibrosis
[43]. Our mouse model has now shown that sustained overex-
pression of HIF-2a alone is sufficient to induce tubulointerstitial
Figure 5. Generation of Ksp/tmHIF-2a.HA transgenic mice. A. Schematic representation of the pcKsp/tmHIF-2a.HA expression vector used for
pronucleus injection consisting of a 1.3 kb Ksp-promoter fragment and an HA-tagged mutated HIF-2a triple mutant cDNA (Ksp, kidney specific; tm,
triple mutant; UTR, untranslated region; HA-tag, influenza hemagglutinin epitope tag; poly-A site, poly-adenylation site). Injection of the Ksp/tmHIF-
2a.HA construct successfully produced transgenic mice. Two of these were chosen and bred into homozygous strains, which was confirmed by
genotyping for Ksp/tmHIF-2a integration and referred as Ksp/tmHIF-2a strain 33 and strain 39, respectively (data not shown). B. Analysis by RT-PCR
detected transgenic tmHIF-2a.HA mRNA expression only in whole kidney RNA extracts from mice of strain 39. C. tmHIF-2a.HA protein expression was
analyzed in whole kidney extracts from both strains by immunoblot. In parallel to the RNA expression, transgenic tmHIF-2a.HA protein was only
expressed in strain 39. Based on these data strain 39 has been termed as tmHIF-2a.HA(+), whereas mice from strain 33 have been defined as tmHIF-
2a.HA (2) and served as control strain, having the transgene integrated but not expressed. D. The localization of tmHIF-2a.HA in the mouse kidney
was next analyzed by immunohistochemistry against HIF-2a and the HA-tag of the transgene on consecutive sections. Transgenic tmHIF-2a.HA
expression was detected in tubular epithelial cells for HIF-2a (left hand panels) as well the HA-tag (right hand panels). E. Kidneys of the tmHIF-
2a.HA(2) control strain were negative for both antibodies.
doi:10.1371/journal.pone.0031034.g005
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Figure 6. tmHIF-2a.HA(+) mice develop renal fibrosis and have impaired renal function. A. Representative photographs of the whole
kidney from 15 month old tmHIF-2a.HA transgenic mice. The tmHIF-2a.HA(2) kidneys show a smooth surface, whereas the tmHIF-2a.HA(+) kidneys
have an irregular surface structure. B. Immunohistological staining against collagen I shows increased interstitial deposition in close proximity to
tmHIF-2a.HA expression in the transgenic kidney. C. Renal fibrosis was scored after SiriusRed staining of collagens. Increased fibrosis was detected in
the kidneys of tmHIF-2a.HA(+) mice (results represent mean values of analyzed animals per strain with the error bars being standard deviation; tmHIF-
2a.HA(2), n = 10; tmHIF-2a.HA(+), n = 11; * indicates p,0.05). D. The mRNA expression of the fibrosis associated gene TGFb1 was analyzed by
HIF-2a Induces Fibrosis & Cysts
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fibrosis and renal insufficiency, perhaps partly mediated by
induction of TGFb1. The molecular mechanism of TGFb
stimulation and subsequent fibrogenesis in our model is unclear
to date. However, a number of fibrogenic pathways have been
described which appear to be influenced after prolonged hypoxia
in the kidney, such as PAI-1, CTGF and TGFß [39] or lysyl
oxidases [44]. Interestingly, all these effects have so far been
attributed to HIF-1a, rather than HIF-2a. However, since renal
tubular cells do not physiologically express HIF-2a this effect may
have been impossible to observe in vivo. The origin of renal
fibrogenesis is discussed controversially in the literature (transdif-
ferentiated epithelia [45] or extrarenal neurocrest derived
fibroblasts [46]. Of note, in our model fibrogenesis clearly stems
from a characteristic change in epithelial cells. The irregular and
rough appearance of the transgenic kidneys probably stems largely
from fibrotic retractions, as can be observed in severe human
CKD. However, in some cases cysts could also cause the rough
appearance wherever these structures bulge out of the surface. We
believe that the former is the leading cause for this phenotype,
since the latter only occurs regionally.
Our study was undertaken in order to improve the understand-
ing of differential effects of HIF-1a and HIF-2a in the kidney.
There are a number of limitations to our approach, such as the use
of different promotors of our genetic models resulting in the
targeting of differing nephron segments. Furthermore, it is unclear
whether the observed phenotype is specific for.
HIF-2 activation, or whether it could also be achieved by
overexpression of HIF-1, possibly by overlapping target genes.
Finally, we have seen the described phenotype only in ageing mice,
which suggests that the effects are rather mild in nature. Therefore,
further studies will be needed to confirm and expand on our data.
However, our data imply that the switch towards tubular HIF-2a
expression is an important mediator of renal tumorigenesis, which
can be achieved by VHL inactivation. The observed phenotype with
renal cysts, tubulointerstitial fibrosis and CKD may share common
pathways, but it could also be caused by parallel mechanisms. Of
note, at least in mice HIF-2a appears not to be an independent
oncogene. Hence, its overexpression may be an important early step
in tumorigenesis but is not sufficient to induce RCCs, which may also
account for the majority of early lesions in human VHL kidneys.
Figure 7. Renal cyst development in aged tmHIF-2a.HA(+) mice. 12 month and older tmHIF-2a.HA(+) mice develop multiple renal cysts,
mainly in the kidney cortex. These partly form around glomeruli, where the glomerular tuft can be seen (arrows in A). Other cysts arise from distal
tubular segments, where transgenic tmHIF-2a.HA expression can be detected in the epithelial lining of the cysts by immunohistochemistry against
the HA-tag (arrows in C). In contrast, the glomerular cysts do not show transgene expression, with occasional positive labelling of tubular segments in
the vicinity (D).
doi:10.1371/journal.pone.0031034.g007
quantitative real-time PCR in whole kidney extracts. The expression was clearly up-regulated in the tmHIF-2a.HA(+) mice (results represent mean
values with the error bars being standard deviation; n = 5 per strain). E. Renal function was analyzed by measurement of creatinine in the serum of the
transgenic mice. tmHIF-2a.HA(+) mice have significantly increased plasma creatinine levels (* indicates p,0.05).
doi:10.1371/journal.pone.0031034.g006
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Materials and Methods
Generation of plasmid DNA, mouse strains and
experimental animal protocols
For the generation of HIF-2a transgenic mice, a mutated and
HA-tagged cDNA of HIF-2a was used as previously described
(triple mutant tmHIF-2a; [8,47]). The product is constitutively
expressed and active, independent of oxygen levels. A 1.3 kb
fragment of the kidney-specific (Ksp-) cadherin 16 promoter
(described in [48]) was fused at its 39-end to a b-globin intron and
cloned into pcDNA3 generating the vector pcKsp/betaGl.
Thereby the internal CMV promoter of the pcDNA3 backbone
was deleted. The HA-tagged tmHIF-2a cDNA was cloned into
pcKsp/betaGl at the 39-site of the b-globin intron, generating the
expression vector pcKsp/tmHIF-2a.HA. Pronucleus injection of
the Ksp/tmHIF-2a.HA construct successfully produced transgenic
mice in a C57Bl10xCBA/Ca hybrid background.
Conditional VHL knockout mice were generated by crossbreed-
ing three different transgenic mouse lines: a) floxed VHL mice
(Jackson Laboratories, Sacramento, CA) [49], b) LC-1 transgenic
mice bearing Cre-recombinase expression under the control of the
bidirectional Ptet promoter [50] and c) mice which express a reverse
tetracycline-dependent transactivator under control of the Pax8
promoter [28] and are described previously [27]. For the induction
of the VHL knockout, mice received 0.2 mg/ml doxycycline/5%
glucose in the drinking water for 3 days.
All procedures involving mice were approved by the institu-
tional review board (file number 31/25/04, University of
Erlangen, Germany) and were in accordance with the National
Institutes of Health guidelines. All data provided in the manuscript
are pooled data from male and female mice.
Renal function
Blood samples were taken immediately from sacrificed animals
by aspiration from the heart. Plasma creatinine and urea were
enzymatically measured using the Integra 800 (Roche).
Collection of human tissues
RCC specimens were from historical collections [17,19]
collected from mostly radical tumor-nephrectomies and fixed in
4% paraformaldehyde (PFA). Written informed consent was
obtained from each patient before nephrectomy. Paraformalde-
hyde fixed kidney specimens from victims of CO intoxication were
from forensic medicine.
Immunohistochemistry and antibodies
Paraffin sections (2 to 4 mm) were dewaxed in xylene and
rehydrated in a series of ethanol washes. Immunohistochemistry
was performed as described previously [51]. Detailed information
for all primary antibodies is given in supplementary table S1. For
detection of HIF-1a, HIF-2a and HA the signal amplification
system (CSA) from DAKO (Glostrup, Denmark) was used
according to the manufacturer’s instructions and described in
Rosenberger [6]. Biotinylated secondary anti-mouse, -rabbit, -
sheep or -rat antibodies were from DAKO. Slides were partially
counterstained with hematoxylin. Signals were analyzed with a
Leica DMRB microscope (Leica, Bensheim, Germany). Photo-
graphs were digitally recorded by means of a Visitron system
(Visitron, Puchheim, Germany).
Protein extraction and immunoblot analysis
Cells were homogenized into extraction buffer (7 M urea, 10%
glycerol, 10 mM Tris-HCl pH 6.8, 1% sodium dodecyl sulphate
[SDS], 5 mmol/L dithiothreitol, 1 mM 4-(2-aminoethyl)-benzen-
sulfonylfluorid [AEBSF], Complete Mini EDTA-free) using a T8
Ultra-Turrax homogenizer (IKA, Staufen, Germany) for 10 sec-
onds at full speed. Extracts were quantified using the DC protein
assay (BioRad, Munich, Germany). Proteins were resolved in 10%
SDS polyacrylamide gels and transferred to Immobilon P
(Millipore, Bedford, MA) overnight in blotting buffer (10 mM
Tris, 100 mM glycine, 10% methanol, 0.05% SDS). Membranes
were blocked with 3% fat-free dried milk in PBS with 0.1%
Tween20 and probed with monoclonal antibodies against
hemagglutinin tag (HA; 0.1 mg/ml; clone 3F10, Roche, Penzberg,
Germany), and ß-Actin (0.48 ng/ml; clone AC-15, Sigma) and
HRP-conjugated secondary goat-anti-rat (0.8 ng/ml; Dianova,
Hamburg, Germany) and goat-anti-mouse antibodies (0.5 ng/ml;
DAKO). Signals were visualized by chemiluminescence (Pierce,
Rockford, IL). Displayed results are representative data of
independent experiments.
Cell culture and transient transfection assays
HeLa (human cervical cancer cell line), COS-7 (monkey kidney
fibroblast cell line), HEK293 (human embryonic kidney fibroblast
cell line) and OK (opossum renal tubular cell line) cells were from
the European Cell Collection (ECACC). All cell lines were
cultured in DMEN, 10% fetal calf serum, 100 U/ml penicillin,
0.1 mg/ml streptomycin (all from PAA).
For 24 h overexpression of triple-mutant HIF-2a, cells were
seeded in 10 cm dishes and transfected with jetPei transfection
reagent (Polyplus, New York, U.S.A.) following the manufacturer’s
instructions with 10 mg of the plasmid pcKsp/tmHIF-2a.HA or
CMV promoter driven pctmHIF-2a.HA ([52], [47]) as positive
control and pcDNA3 empty vector as negative control.
For luciferase reporter assays cells were seeded in 24-well plates
and transfected at a confluency of ,50–60% with 0.5 mg of the
6xHRE luciferase reporter plasmids or 0.5 mg of the EPO-
enhancer reporter plasmid and 0.1 mg pCMV-b-galactosidase
expression vector (Stratagene, La Jolla, CA) using jetPei
transfection reagent. For HIF-2a overexpression 50 ng of the
expression vectors pcKsp/tmHIF-2a.HA or an equimolar amount
of the empty vector pcKsp/betaGl was co-transfected. Luciferase
activities were determined using the Luciferase Assay Reagent
(Promega, Madison, WI) and normalized to b-galactosidase
expression.
In vitro generation of recombinant protein
Recombinant tmHIF-2a.HA protein was generated from the
expression vector pctmHIF-2a.HA by using the TNTH Quick
coupled transcription/translation system (Promega) according to
manufacturer’s instruction. pcDNA3 empty vector was used as a
negative control.
RT-PCR and quantitative real-time PCR
Total RNA extracts were prepared by the use of RNAzol B
(Biogenesis, Poole, U.K.) according to manufacturer’s instructions.
cDNA was generated using Superscript II RT (Invitrogen)
according to manufacturer’s instructions from 200 ng of total
RNA.
The mRNA expression of Ksp-promotor driven tmHIF-2a.HA
in the kidneys of transgenic mice was determined by RT-PCR
using the following primers: mHIF2Eco-fw 59-CGATGAATT-
CACCCAAAAATCTATGAG-39; HA-tag-rev 59-GTAGTCT-
GGGACGTCGTATGG-39.
The mRNA expression of PHD3 and VEGF was determined by
quantitative real-time PCR in duplicates with the Power SYBR
Green PCR Mastermix (Applied Biosystems) according to
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manufacturer’s instructions. Normalization was to HPRT house-
keeping gene and fold-expression level was calculated using the
DDct method. The following primers were used: PHD3 fw 59-
CTATGTCAAGGAGCGGTCCAA-39, PHD3 rev 59-GTCCA-
CATGGCGAACATAACC-39; VEGF fw 59-CAGGCTGCTG-
TAACGATGAA-39, VEGF rev 59-TATGTGCTGGCTTTG-
GTGAG-39; HPRT fw 59-GTTGGATACAGGCCAGACT-
TTGT-39, HPRT rev 59-CCACAGGACTAGAACACCTGC-39.
The mRNA expression of Glut1, TGF-a and TGF-b1 was
determined by quantitative real-time PCR in duplicates with the
Taqman Gene Expression System (Applied Biosystems) according
to manufacturer’s instructions. Normalization was to b-2 micro-
globulin housekeeping gene and fold-expression level was
calculated using the DDct method. The following Taqman Gene
Expression Assays were used: Glut1 Assay ID Mm01192270_m1;
TGF-a Assay ID Mm00446231_m1; TGF-b1 Assay ID
Mn00441727_g1; b2-m Assay ID Mm00437762_m1.
Determination of fibrosis and vascularization score
The fibrosis level was quantified after SiriusRed staining of
kidney sections. The score was determined by the percentage of
staining in 15 randomly selected optical fields per kidney section at
a 2006 magnification according to the following ranking: 0% -
score 0; 1–25% - score 1, 25–50% - score 2; 50–75% - score 3,
more than 75% - score 4. Vascularization was quantified by
counting signals in 15 randomly selected optical fields per kidney
section at a 2006 magnification after immunohistochemical
staining against MECA-32. The origin of the samples was blinded
to the pathologist doing the scoring.
Supporting Information
Figure S1 In vitro analysis of the pcKsp/tmHIF-2a.HA
expression vector. A. Transient expression of tmHIF-2a.HA
under control of the Ksp-promoter or CMV-promoter (positive
control) and expression of the empty vector pcDNA3 (negative
control) was analyzed in HeLa, COS-7, HEK293 and OK cells.
Expression of tmHIF-2a.HA under standard promoter control
occurred in all cell lines, whereas Ksp-promoter driven tmHIF-
2a.HA is only expressed in the kidney epithelial cell line. B.
Transactivation functionality of the pcKsp/tmHIF-2a.HA con-
struct was analyzed by two HIF dependent luciferase reporter in
renal tubular OK cells. Forced expression of the pcKsp/tmHIF-
2a.HA construct induced 6xHRE and EPO-E reporter gene
expression up to 3.4-fold (mean values of three independent
experiments with the error bars being standard deviation;
* indicates p,0.05).
(TIF)
Figure S2 tmHIF-2a-HA is expressed in the distal tubule
and the collecting duct. Transgenic tmHIF-2a.HA expression
is localized in the distal part of the renal tubule and the collecting
duct shown by immunohistochemistry. HA staining colocalized
with staining against the tubular segment markers NCC (A),
11bHSD (B) and AQP-2 (C) in the distal tubulus and the collecting
duct.
(TIF)
Figure S3 Analysis of kidneys from tmHIF-2a.HA
overexpressing mice. The kidneys of tmHIF-2a.HA(+) trans-
genic mice show a significantly reduced weight compared to the
tmHIF-2a.HA(2) control animals (results represent mean values of
analyzed animals per strain with the error bars being standard
deviation; tmHIF-2a.HA(2) n = 16; tmHIF-2a.HA(+) n = 19;
* indicates p,0.05). B. Renal fibrosis was analyzed by SiriusRed
staining of connective tissue, mainly collagens. Kidneys of tmHIF-
2a.HA(+) mice displayed strong fibrotic staining. C. HIF target
gene activation was analyzed by quantitative real-time PCR of
whole kidney extracts from Ksp/tmHIF-2a.HA transgenic mice at
different ages. PHD3 expression was clearly increased in the
kidneys of tmHIF-2a.HA(+) mice. TGFa, Glut1 and VEGF
expression were moderately induced in the tmHIF-2a.HA(+)
animals (results represent mean values of tested animals per strain
with the error bars being standard deviation; n= 5 per strain). D.
Vascularization of the transgenic kidneys was analyzed by
endothelial MECA-32 staining and determination of the staining
signals per mm2. tmHIF-2a.HA(+) mice displayed a stronger
vascularization of their kidneys (cap, capillary; results represent
mean values of analyzed animals per strain with the error bars
being standard deviation; tmHIF-2a.HA(2), n = 9; tmHIF-
2a.HA(+), n = 11; * indicates p,0.05).
(TIF)
Figure S4 Cilia in kidneys from tmHIF-2a.HA overex-
pressing mice. Cilia from tmHIF-2a.HA(+) transgenic mice
were visualized with an anti-Acetylated Tubulin antibody (clone 6-
11B-1, Sigma; sec. antibody AlexaFlour 594) and co-stained with
an anti-NCC (Oregon Health & Science University; sec. antibody
AlexaFlour 488) or anti-11bHSD (Millipore, Billerica, MA; sec.
antibody AlexaFlour 488) antibody using the mouse on mouse Kit
(M.O.M.-Kit) from Vector Laboratories (Burlingame, CA) ac-
cording to the manufactures instructions. The figure shows
representative data from old and young mice co-stained for Ac-
Tubulin and NCC (A) or Ac-Tubulin and 11bHSD (B),
respectively. All tubuli identified by the segment specific markers
showed clearly stained cilia strongly suggesting that the overex-
pression of HIF-2a does not influence cilia formation.
(TIF)
Table S1 Primary antibodies. Primary antibodies used for
immunohistochemistry are listed with inclusion of source and
dilution.
(DOC)
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